Join
Live feed
·
INSIDERFilingvia Quantisnow
Concert Pharmaceuticals Inc. logo

SEC Form 4: Auchincloss Thomas G was granted 16,400 shares, increasing direct ownership by 93% to 34,025 units

ByQuantisnow·Wall Street's wire, on your screen.
CNCE· Concert Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNCE (Concert Pharmaceuticals Inc.) and more on Quantisnow.